Advertisement
For patients undergoing total knee arthroplasty and total hip arthroplasty for osteoarthritis

Knee, Hip Arthroplasty Tied to Increased Short-Term MI Risk

0
Increased risk of myocardial infarction in first post-op month; but not during overall follow-up
Age-related changes to the mass and volume of the left ventricle occur differently in men and women

Age Affects Left Ventricle Differently in Men, Women

0
In men, the longitudinal changes in LV mass opposite of cross-sectional changes
Markets with greater increases in physician-hospital integration show greater increases in spending for outpatient care

Outpatient Spending Higher With Physician-Hospital Integration

0
Authors say increased spending attributable to price increases, not utilization changes
Preeclampsia may increase risk of congenital heart defects

Preeclampsia Tied to Congenital Heart Defects

0
But researchers stress the risk is still very low
Some energy drinks appear to significantly improve endothelial function

Only Some Energy Drinks Change Endothelial Function

0
Caffeine content does not seem to be responsible for these changes
In the Action to Control Cardiovascular Risk in Diabetes trial

Insulin Dose Doesn’t Up Mortality in ACCORD Trial

0
No significant association remained after adjustment for baseline covariates
Longer QRS duration predicts cardiac death and nonfatal myocardial infarction in patients with coronary artery disease

Longer QRS Duration Predicts Cardiac Death, Heart Attack

0
Findings in patients with known, suspected coronary artery disease
Praxbind (idarucizumab) has been approved for use in patients who are taking the anticoagulant Pradaxa (dabigatran) when there is an urgent need to reverse Pradaxa's anticoagulant effects

FDA Approves Praxbind to Reverse Pradaxa’s Effect

0
Praxbind cleared for emergency use with Pradaxa when bleeding can't be controlled
Lipid profiles seem to be associated with tendon health

Review Links Lipid Profiles With Tendon Health

0
Altered tendon structure or pain linked to higher total cholesterol, LDL cholesterol, triglycerides
Paclitaxel-eluting stents are not noninferior to everolimus-eluting stents for patients with diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention

Paclitaxel-Eluting Not Noninferior to Everolimus-Eluting Stent

0
Findings in patients with diabetes mellitus and coronary artery disease undergoing PCI